| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20067481 | HPV | ENSG00000170820.12 | protein_coding | FSHR | No | No | 2492 | A0A1D5RMN4 P23945 |
| TVIS20033232 | HPV | ENSG00000170820.12 | protein_coding | FSHR | No | No | 2492 | A0A1D5RMN4 P23945 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FSHR |
|---|---|
| DrugBank ID | DB04786 |
| Drug Name | Suramin |
| Target ID | BE0000387 |
| UniProt ID | P23945 |
| Regulation Type | antagonist |
| PubMed IDs | 18991754; 17552360 |
| Citations | McGeary RP, Bennett AJ, Tran QB, Cosgrove KL, Ross BP: Suramin: clinical uses and structure-activity relationships. Mini Rev Med Chem. 2008 Nov;8(13):1384-94.@@Bose CK: Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC). J Exp Ther Oncol. 2007;6(3):201-4. |
| Groups | Investigational |
| Direct Classification | Benzanilides |
| SMILES | CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O |
| Pathways | |
| PharmGKB | PA10292 |
| ChEMBL | CHEMBL265502 |
